Last 12 months
Inside the activity.
0 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 10, 2025 Filed Feb 12, 2025 16:09 UTC |
Kuhlmann Shirley R.EVP and General Counsel
|
GrantCommon Stock | 29,030 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-002175 · form4.xml · nonDerivative · entry 2 Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,179 F2 · shares: Effective February 10, 2025, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 29,030 performance share units ("PSUs") granted in the Issuer's three prior fiscal years. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 16:09 UTC |
Kuhlmann Shirley R.EVP and General Counsel
|
GrantCommon Stock | 40,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-002175 · form4.xml · nonDerivative · entry 1 Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,149 F1 · shares: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2026, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:10 UTC |
Heffernan Michael ThomasDirector
|
GrantCommon Stock | 4,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-002181 · form4.xml · nonDerivative · entry 1 Heffernan Michael Thomas · CIK 0001448914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,328 F1 · shares: Reflects the grant of fully-vested restricted stock units ("RSUs") granted as compensation for the Reporting Person's service as interim Chief Executive Officer in 2024. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:10 UTC |
Smith Thomas BEVP and Chief Medical Officer
|
Tax withholdingCommon Stock | 4,399 | $30.52 | $134,257.48 |
DisclosureSEC source: 0001062993-25-002180 · form4.xml · nonDerivative · entry 4 Smith Thomas B · CIK 0001748462 · EVP and Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,742 F5 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:10 UTC |
Smith Thomas BEVP and Chief Medical Officer
|
Tax withholdingCommon Stock | 1,498 | $30.52 | $45,718.96 |
DisclosureSEC source: 0001062993-25-002180 · form4.xml · nonDerivative · entry 3 Smith Thomas B · CIK 0001748462 · EVP and Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,141 F4 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:10 UTC |
Smith Thomas BEVP and Chief Medical Officer
|
GrantCommon Stock | 5,313 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-002180 · form4.xml · nonDerivative · entry 2 Smith Thomas B · CIK 0001748462 · EVP and Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,639 F3 · shares: Effective February 10, 2025, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 5,313 performance share units ("PSUs") granted in the Issuer's prior fiscal year. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:10 UTC |
Smith Thomas BEVP and Chief Medical Officer
|
GrantCommon Stock | 33,762 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-002180 · form4.xml · nonDerivative · entry 1 Smith Thomas B · CIK 0001748462 · EVP and Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,326 F1 · shares: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2026, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. F2 · balance_after: Includes 373 and 375 shares acquired on July 19, 2024 and January 17, 2025, respectively, under the Issuer's employee stock purchase plan. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:10 UTC |
Dreyer ScottEVP & Chief Commercial Officer
|
Tax withholdingCommon Stock | 21,670 | $30.52 | $661,368.40 |
DisclosureSEC source: 0001062993-25-002179 · form4.xml · nonDerivative · entry 4 Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,706 F4 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:10 UTC |
Dreyer ScottEVP & Chief Commercial Officer
|
Tax withholdingCommon Stock | 7,953 | $30.52 | $242,725.56 |
DisclosureSEC source: 0001062993-25-002179 · form4.xml · nonDerivative · entry 3 Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,376 F3 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:10 UTC |
Dreyer ScottEVP & Chief Commercial Officer
|
GrantCommon Stock | 26,411 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-002179 · form4.xml · nonDerivative · entry 2 Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 177,329 F2 · shares: Effective February 10, 2025, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 26,411 performance share units ("PSUs") granted in the Issuer's three prior fiscal years. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:10 UTC |
Dreyer ScottEVP & Chief Commercial Officer
|
GrantCommon Stock | 45,016 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-002179 · form4.xml · nonDerivative · entry 1 Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,918 F1 · shares: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2026, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. Read SEC document |
| February 04, 2025 Filed Feb 5, 2025 22:30 UTC |
Lurker NancyDirector
|
GrantCommon Stock | 12,726 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-001754 · form4.xml · nonDerivative · entry 1 Lurker Nancy · CIK 0001450485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,726 F1 · shares: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on February 4, 2026, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on such date in shares of the Issuer's common stock. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 16:12 UTC |
Kuhlmann Shirley R.EVP and General Counsel
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 27,500 | $0.00 Strike: $21.34 | $0.00 |
DisclosureSEC source: 0001062993-25-000761 · form4.xml · derivative · entry 4 Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,500 shares Expires 2030-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2024. F4 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 16:12 UTC |
Kuhlmann Shirley R.EVP and General Counsel
|
SaleCommon Stock | 6,100 | $33.64 | $205,220.47 |
DisclosureSEC source: 0001062993-25-000761 · form4.xml · nonDerivative · entry 3 Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,184 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2024. F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.42 to $33.41, inclusive. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 16:12 UTC |
Kuhlmann Shirley R.EVP and General Counsel
|
SaleCommon Stock | 21,400 | $32.87 | $703,407.30 |
DisclosureSEC source: 0001062993-25-000761 · form4.xml · nonDerivative · entry 2 Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125,284 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2024. F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.43 to $33.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 16:12 UTC |
Kuhlmann Shirley R.EVP and General Counsel
|
Exercise / conversionCommon Stock | 27,500 | $21.34 | $586,850.00 |
DisclosureSEC source: 0001062993-25-000761 · form4.xml · nonDerivative · entry 1 Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 146,684 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2024. Read SEC document |
| November 12, 2024 Filed Nov 14, 2024 21:50 UTC |
Karnani VikramDirector · President and CEO
|
GrantStock Option (Right to Purchase) · Derivative | 130,344 | $0.00 Strike: $31.41 | $0.00 |
DisclosureSEC source: 0001062993-24-019165 · form4.xml · derivative · entry 2 Karnani Vikram · CIK 0001699488 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,344 Underlying: Common Stock · 130,344 shares Expires 2034-11-12 F2 · derivative.exercise_date: Twenty-five percent (25%) of the option shall vest and become exercisable on November 12, 2025, with the balance vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| November 12, 2024 Filed Nov 14, 2024 21:50 UTC |
Karnani VikramDirector · President and CEO
|
GrantCommon Stock | 105,972 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-019165 · form4.xml · nonDerivative · entry 1 Karnani Vikram · CIK 0001699488 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,972 F1 · shares: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Twenty-five percent (25%) of the RSUs shall vest on November 12, 2025, with the balance vesting in three annual installments thereafter, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 20:32 UTC |
Smith Thomas BEVP and Chief Medical Officer
|
SaleCommon Stock | 9,593 | $36.62 | $351,319.64 |
DisclosureSEC source: 0001062993-24-016699 · form4.xml · nonDerivative · entry 1 Smith Thomas B · CIK 0001748462 · EVP and Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,816 F1 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.56 to $36.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 06, 2024 Filed Sep 6, 2024 17:52 UTC |
Kuhlmann Shirley R.EVP and General Counsel
|
SaleCommon Stock | 977 | $37.46 | $36,594.12 |
DisclosureSEC source: 0001062993-24-016277 · form4.xml · nonDerivative · entry 3 Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,184 F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.455 to $37.4592, inclusive. Read SEC document |
| September 05, 2024 Filed Sep 6, 2024 17:52 UTC |
Kuhlmann Shirley R.EVP and General Counsel
|
SaleCommon Stock | 2,400 | $39.14 | $93,941.04 |
DisclosureSEC source: 0001062993-24-016277 · form4.xml · nonDerivative · entry 2 Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,161 F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.01 to $39.20, inclusive. Read SEC document |
| September 05, 2024 Filed Sep 6, 2024 17:52 UTC |
Kuhlmann Shirley R.EVP and General Counsel
|
SaleCommon Stock | 16,848 | $38.18 | $643,256.64 |
DisclosureSEC source: 0001062993-24-016277 · form4.xml · nonDerivative · entry 1 Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,561 F1 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.00 to $38.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 16:06 UTC |
Kuhlmann Shirley R.EVP and General Counsel
|
SaleCommon Stock | 700 | $33.22 | $23,254.00 |
DisclosureSEC source: 0001062993-24-011979 · form4.xml · nonDerivative · entry 2 Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 139,409 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2024. F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.19 to $33.31, inclusive. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 16:06 UTC |
Kuhlmann Shirley R.EVP and General Counsel
|
SaleCommon Stock | 24,300 | $32.55 | $790,926.12 |
DisclosureSEC source: 0001062993-24-011979 · form4.xml · nonDerivative · entry 1 Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,109 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2024. F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.18 to $33.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| May 28, 2024 Filed May 29, 2024 16:29 UTC |
Tupper ColleenEVP & Chief Financial Officer
|
SaleCommon Stock | 19,710 | $34.21 | $674,367.80 |
DisclosureSEC source: 0001062993-24-011413 · form4.xml · nonDerivative · entry 1 Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 130,845 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2024. F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.94 to $34.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2). Read SEC document |
| May 24, 2024 Filed May 28, 2024 20:22 UTC |
Dreyer ScottEVP & Chief Commercial Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 23,791 | $0.00 Strike: $24.03 | $0.00 |
DisclosureSEC source: 0001062993-24-011338 · form4.xml · derivative · entry 6 Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,791 shares Expires 2028-04-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| May 24, 2024 Filed May 28, 2024 20:22 UTC |
Dreyer ScottEVP & Chief Commercial Officer
|
SaleCommon Stock | 56,807 | $33.98 | $1,930,455.24 |
DisclosureSEC source: 0001062993-24-011338 · form4.xml · nonDerivative · entry 4 Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,902 F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.68 to $34.25, inclusive. Read SEC document |
| May 24, 2024 Filed May 28, 2024 20:22 UTC |
Dreyer ScottEVP & Chief Commercial Officer
|
Exercise / conversionCommon Stock | 23,791 | $24.03 | $571,697.73 |
DisclosureSEC source: 0001062993-24-011338 · form4.xml · nonDerivative · entry 3 Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,709 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2024 Filed May 28, 2024 20:22 UTC |
Dreyer ScottEVP & Chief Commercial Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 51,209 | $0.00 Strike: $24.03 | $0.00 |
DisclosureSEC source: 0001062993-24-011338 · form4.xml · derivative · entry 5 Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,791 Underlying: Common Stock · 51,209 shares Expires 2028-04-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| May 23, 2024 Filed May 28, 2024 20:22 UTC |
Dreyer ScottEVP & Chief Commercial Officer
|
SaleCommon Stock | 51,209 | $33.82 | $1,732,093.22 |
DisclosureSEC source: 0001062993-24-011338 · form4.xml · nonDerivative · entry 2 Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,918 F1 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.36 to $34.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| May 23, 2024 Filed May 28, 2024 20:22 UTC |
Dreyer ScottEVP & Chief Commercial Officer
|
Exercise / conversionCommon Stock | 51,209 | $24.03 | $1,230,552.27 |
DisclosureSEC source: 0001062993-24-011338 · form4.xml · nonDerivative · entry 1 Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190,127 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2024 Filed May 16, 2024 23:21 UTC |
Heffernan Michael ThomasDirector
|
GrantCommon Stock | 7,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-010537 · form4.xml · nonDerivative · entry 1 Heffernan Michael Thomas · CIK 0001448914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,508 F1 · shares: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on May 16, 2025, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock. Read SEC document |
| May 16, 2024 Filed May 16, 2024 23:22 UTC |
Freund John GordonDirector
|
GrantCommon Stock | 7,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-010540 · form4.xml · nonDerivative · entry 1 Freund John Gordon · CIK 0001296771 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,468 F1 · shares: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on May 16, 2025, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock. Read SEC document |
| May 16, 2024 Filed May 16, 2024 23:23 UTC |
SANTINI GINODirector
|
GrantCommon Stock | 7,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-010543 · form4.xml · nonDerivative · entry 1 SANTINI GINO · CIK 0001276038 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,656 F1 · shares: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on May 16, 2025, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock. Read SEC document |
| May 16, 2024 Filed May 16, 2024 23:23 UTC |
Melincoff Gwen ADirector
|
GrantCommon Stock | 7,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-010542 · form4.xml · nonDerivative · entry 1 Melincoff Gwen A · CIK 0001614890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,468 F1 · shares: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on May 16, 2025, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock. Read SEC document |
| May 16, 2024 Filed May 16, 2024 23:23 UTC |
McFarlane Neil F.Director
|
GrantCommon Stock | 7,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-010541 · form4.xml · nonDerivative · entry 1 McFarlane Neil F. · CIK 0001681098 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,365 F1 · shares: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on May 16, 2025, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock. Read SEC document |
| May 16, 2024 Filed May 16, 2024 23:22 UTC |
Fallon John A.Director
|
GrantCommon Stock | 7,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-010539 · form4.xml · nonDerivative · entry 1 Fallon John A. · CIK 0001560152 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,843 F1 · shares: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on May 16, 2025, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock. Read SEC document |
| May 16, 2024 Filed May 16, 2024 23:22 UTC |
Balice-Gordon Rita J.Director
|
GrantCommon Stock | 7,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-010538 · form4.xml · nonDerivative · entry 1 Balice-Gordon Rita J. · CIK 0001825625 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,488 F1 · shares: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on May 16, 2025, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock. Read SEC document |
| May 16, 2024 Filed May 16, 2024 23:20 UTC |
BOHLIN GAREN GDirector
|
GrantCommon Stock | 7,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-010536 · form4.xml · nonDerivative · entry 3 BOHLIN GAREN G · CIK 0001254705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,468 F2 · shares: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on May 16, 2025, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock. Read SEC document |
| May 14, 2024 Filed May 16, 2024 23:20 UTC |
BOHLIN GAREN GDirector
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 28,985 | $0.00 Strike: $5.73 | $0.00 |
DisclosureSEC source: 0001062993-24-010536 · form4.xml · derivative · entry 4 BOHLIN GAREN G · CIK 0001254705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,985 shares Expires 2025-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| May 14, 2024 Filed May 16, 2024 23:20 UTC |
BOHLIN GAREN GDirector
|
SaleCommon Stock | 28,985 | $32.30 | $936,311.15 |
DisclosureSEC source: 0001062993-24-010536 · form4.xml · nonDerivative · entry 2 BOHLIN GAREN G · CIK 0001254705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,775 F1 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.00 to $32.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 14, 2024 Filed May 16, 2024 23:20 UTC |
BOHLIN GAREN GDirector
|
Exercise / conversionCommon Stock | 28,985 | $5.73 | $166,084.05 |
DisclosureSEC source: 0001062993-24-010536 · form4.xml · nonDerivative · entry 1 BOHLIN GAREN G · CIK 0001254705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,760 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 21:26 UTC |
Smith Thomas BEVP and Chief Medical Officer
|
SaleCommon Stock | 995 | $36.76 | $36,580.18 |
DisclosureSEC source: 0001062993-24-005212 · form4.xml · nonDerivative · entry 1 Smith Thomas B · CIK 0001748462 · EVP and Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,409 Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 21:14 UTC |
Dreyer ScottEVP & Chief Commercial Officer
|
SaleCommon Stock | 664 | $37.15 | $24,669.59 |
DisclosureSEC source: 0001062993-24-004754 · form4.xml · nonDerivative · entry 2 Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 138,918 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 9, 2023. F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.01 to $37.50, inclusive. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 21:14 UTC |
Dreyer ScottEVP & Chief Commercial Officer
|
SaleCommon Stock | 9,336 | $36.38 | $339,600.73 |
DisclosureSEC source: 0001062993-24-004754 · form4.xml · nonDerivative · entry 1 Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 139,582 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 9, 2023. F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.96 to $36.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 16:15 UTC |
Tupper ColleenEVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 9,453 | $33.70 | $318,566.10 |
DisclosureSEC source: 0001062993-24-003170 · form4.xml · nonDerivative · entry 4 Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,555 F4 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 16:15 UTC |
Tupper ColleenEVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 16,868 | $33.70 | $568,451.60 |
DisclosureSEC source: 0001062993-24-003170 · form4.xml · nonDerivative · entry 3 Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,008 F3 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 16:15 UTC |
Tupper ColleenEVP & Chief Financial Officer
|
GrantCommon Stock | 30,856 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-003170 · form4.xml · nonDerivative · entry 2 Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,876 F2 · shares: Effective February 12, 2024, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 30,856 performance share units ("PSUs") granted in the Issuer's three prior fiscal years. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 16:15 UTC |
Tupper ColleenEVP & Chief Financial Officer
|
GrantCommon Stock | 40,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-003170 · form4.xml · nonDerivative · entry 1 Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,020 F1 · shares: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2025, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 16:14 UTC |
Kuhlmann Shirley R.EVP and General Counsel
|
Tax withholdingCommon Stock | 10,610 | $33.70 | $357,557.00 |
DisclosureSEC source: 0001062993-24-003167 · form4.xml · nonDerivative · entry 4 Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,409 F4 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.